Innovation AdvisorGrants and Innovation
About Camilla Pettersson
Camilla Pettersson is team leader for Innovation and Utilization at the Grants- and Innovation Office. Mainly works with planning, strategy and development of the university's support for utilization of knowledge and research (knowledge transfer).
Competences: Master in molecular biology, PhD in medicine, journalism, communication, cooperation with external collaboration partners, innovation, knowledge transfer and utilizaiton in society.
LDL-associated apolipoprotein J and lysozyme are associated with atherogenic properties of LDL found in type 2 diabetes and the metabolic
ApoCIII-Enriched LDL in Type 2 Diabetes Displays Altered Lipid Composition, Increased Susceptibility for Sphingomyelinase and Increased binding to
A Hiukka, Marcus Ståhlman, Camilla Pettersson, Malin Levin, Martin Adiels, Susann Teneberg, ES Leinonen, Lillemor Mattsson Hultén, Olov Wiklund, M Oresic, Sven-Olof Olofsson, MR Taskinen, K Ekroos, Jan Borén
Diabetes - 2009
Studies on the atherogenicity of apoB-containing lipoproteins in type 2
ApoCIII-enriched LDL in type 2 diabetes displays altered lipid composition and increased susceptibility for
Anne Hiukka, Marcus Ståhlman, Camilla Pettersson, Malin Levin, Martin Adiels, Susann Teneberg, Olov Wiklund, Matej Oresic, Sven-Olof Olofsson, Marja-Riitta Taskinen, Kim Ekroos, Jan Borén
CHEMISTRY AND PHYSICS OF LIPIDS - 2008
Increased lipolysis by secretory phospholipase A(2) group V of lipoproteins in diabetic
How can we prevent cardiovascular disease in